Evidence map›Paper›PMID 27098544›Full record

ArticleBioconjugate chemistry2016

Novel Strategy for Preparing Dual-Modality Optical/PET Imaging Probes via Photo-Click Chemistry.

Lingyi Sun, Jiule Ding, Wei Xing, Yongkang Gai, Jing Sheng, Dexing Zeng

Abstract read
In one paragraph

Article in Bioconjugate chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lingyi SunDepartment of Radiology, University of Pittsburgh , Pittsburgh, Pennsylvania 15219, United States.
Jiule DingDepartment of Radiology, University of Pittsburgh , Pittsburgh, Pennsylvania 15219, United States.
Wei XingDepartment of Radiology, Third Affiliated Hospital of Suzhou University , Changzhou City, Jiangsu 213003, China.
Yongkang GaiDepartment of Radiology, University of Pittsburgh , Pittsburgh, Pennsylvania 15219, United States.
Jing ShengDepartment of Radiology, Third Affiliated Hospital of Suzhou University , Changzhou City, Jiangsu 213003, China.
Dexing ZengDepartment of Radiology, University of Pittsburgh , Pittsburgh, Pennsylvania 15219, United States.

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jessie Nedrow · 1988 to 2026
$158.0M
Novel Platform to achieve high avidity of heterodimers for targeted cancer imagingR21EB020737 · NIBIB · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ZENG, DEXING · 2015 to 2016
$424k
Solid-Phase Platform for the Preparation of Dual-receptor Targeted PET AgentsR21EB017317 · NIBIB · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ZENG, DEXING · 2013 to 2014
$415k
NCI NIH HHS P30 CA047904NIBIB NIH HHS R21 EB017317NIBIB NIH HHS R21 EB020737
6 · The paper itself

Abstract

Preparation of small molecule based dual-modality probes remains a challenging task due to the complicated synthetic procedure. In this study, a novel concise and generic strategy for preparing dual-modality optical/PET imaging probes via photo-click chemistry was developed, in which the diazole photo-click linker functioned not only as a bridge between the targeting-ligand and the PET imaging moiety, but also as the fluorophore for optical imaging. A dual-modality AE105 peptidic probe was successfully generated via this strategy and subsequently applied in the fluorescent staining of U87MG cells and the (68)Ga based PET imaging of mice bearing U87MG xenograft. In addition, dual-modality monoclonal antibody cetuximab has also been generated via this strategy and labeled with (64)Cu for PET imaging studies, broadening the application of this strategy to include the preparation of macromolecule based imaging probes.

Indexed as

Click ChemistryPhotochemical ProcessesAnimalsAzolesCell Line, TumorCell Transformation, NeoplasticCetuximabHeterocyclic CompoundsHeterocyclic Compounds, 1-RingHumansMiceOptical ImagingPositron-Emission TomographyRadiopharmaceuticals1,4,7-triazacyclononane-N,N',N''-triacetic acidAzolesCetuximabHeterocyclic CompoundsHeterocyclic Compounds, 1-RingRadiopharmaceuticals

Identifiers

PMID27098544
PMCPMC4871752

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.